corona_2004 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Incyte begins Phase III trial of ruxolitinib to treat Covid-19

The trial will assess the safety and efficacy of ruxolitinib in Covid-19. Credit: Vektorkunst from Pixabay.